Delivery Order SPE2DB20D3103-SPE2DB25FM5G7
Award Date
1/30/25
Potential Completion Date
2/21/25
Potential Value
$24K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D1202|SPE2DB25FUPM0, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $6,421.76 firm fixed-price delivery order is for the supply of RYANODEX 250 MG VIALS, a medical product, with a period of performance ending on February 5, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,816.32, is a delivery order for 4567143430 RYANODEX 250 MG VIALS. The contract has a firm fixed price pricing type and an ultimate completion date of February 24, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
This federal contract award, valued at $4,816.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYANODEX 250 MG VIALS, a specific medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is February 21, 2025. The contract award is not designated with a set-aside requirement, indicating an...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,623.36 Firm Fixed Price delivery order covers the supply of RYANODEX 250 MG VIALS, a specialty pharmaceutical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $9,632.64 and is a Firm Fixed Price Delivery Order for the supply of RYANODEX 250 MG VIALS. The contract has an ultimate completion date of January 30, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is between the Defense Logistics Agency (DLA) Troop Support Medical and the pharmaceutical distributor Amerisourcebergen Drug Corp. The $8,937.84 firm fixed-price delivery order is for the supply of RYANODEX 250MG VIAL 1S, a specialty pharmaceutical product. This award is a task order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,605.44 firm-fixed-price delivery order is for the supply of RYANODEX 250MG VIAL 1S, a medical product, with a period of performance ending on January 29, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, with the ID SPE2DB22D1017|SPE2DB25FE8MP, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,979.28 firm-fixed-price delivery order is for the supply of RYANODEX 250 MG VIALS, a critical medical commodity. The contract has an ultimate completion date of November 26, 2024 and was awarded on November 4, 2024. Amerisourcebergen holds a significant Indefinite...
This federal contract award is for the delivery of RYANODEX 250 MG VIALS to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD). The contract, awarded to AmerisourceBergen Drug Corp's Corporate Office Division, has a ceiling value of $5,958.56 and a completion date of July 23, 2024. It is a Firm Fixed Price Delivery Order contract, without any set-aside designation. AmerisourceBergen, a major pharmaceutical distribution company, holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division. The contract is for the supply of RYANODEX 250 MG VIALS, a pharmaceutical product. The contract has a ceiling value of $1,489.64 and is a firm fixed price delivery order with a period of performance through August 8, 2024. There is no set-aside designation for this award. Amerisourcebergen Drug Corp is a major supplier of...